Credit: Photo: Douglas Levere, University at Buffalo
A novel combination of aztreonam, amikacin and polymyxin B was able to kill E. coli carrying mcr-1 and ndm-5 — genes that make the bacterium immune to last-resort antibiotics.
Credit: Photo: Douglas Levere, University at Buffalo
Fewer than two dozen cases of E. coli carrying mcr-1 have been reported in the U.S., however, the bacteria’s immunity to available antibiotics has left the medical community vulnerable to a massive outbreak of infections.